Depression Clinical Trials in New York

Showing 281-297 of 297 trials

Effects of Antidepressants on Sexual Functioning

NCT00051259

The purpose of this trial is to study the effects of two depression medications on sexual functioning.

GlaxoSmithKline420 participantsStarted Jan 2003

Berkeley, California, United States • Beverly Hills, California, United States • La Mesa, California, United States +20 more locations

COMPLETEDPhase 3< 1 mile

Escitalopram in Adult Patients With Major Depressive Disorder

NCT00668525

This is a short-term study to evaluate the efficacy, safety, and tolerability of escitalopram in adult patients (18 to 65 years of age) with moderate to severe depression. Patients completing the study may be eligible to enter a long-term open-label extension study with escitalopram.

Major Depressive Disorder

Forest Laboratories877 participantsStarted Apr 2008

Phoenix, Arizona, United States • Arcadia, California, United States • Encino, California, United States +42 more locations

Effects of Antidepressants on Sexual Functioning

Escitalopram in Adult Patients With Major Depressive Disorder

Depression Trials in Other Cities

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

fMRI Investigation of Depression in Patients With Epilepsy

Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder

Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression

A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression

Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression

Sequenced Treatment Alternatives to Relieve Depression (STAR*D)

The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis

Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects

Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder

Other Conditions in New York